Cargando…

A Review of Clinical Practice Guidelines for the Management of Hypertriglyceridemia: A Focus on High Dose Omega-3 Fatty Acids

Cardiovascular (CV) disease remains the leading cause of preventable death in the US. Hyperlipidemia is a major modifiable risk factor for CV disease, and after numerous clinical trials have demonstrated that reductions in low-density lipoprotein (LDL) cholesterol with statin therapy can prevent maj...

Descripción completa

Detalles Bibliográficos
Autor principal:	Karalis, Dean G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Healthcare 2016
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5331085/ https://www.ncbi.nlm.nih.gov/pubmed/27981496 http://dx.doi.org/10.1007/s12325-016-0462-y

Ejemplares similares

The clinical relevance of omega-3 fatty acids in the management of hypertriglyceridemia
por: Backes, James, et al.
Publicado: (2016)

Update on the management of severe hypertriglyceridemia – focus on free fatty acid forms of omega-3
por: Pirillo, Angela, et al.
Publicado: (2015)

Treatment of Severe Hypertriglyceridemia During Pregnancy With High Doses of Omega-3 Fatty Acid and Plasmapheresis
por: Nguyen, Nguyen T., et al.
Publicado: (2021)

Do Omega-3 Polyunsaturated Fatty Acids Prevent Cardiovascular Disease? A Review of the Randomized Clinical Trials
por: Kimmig, Lucas M, et al.
Publicado: (2013)

Effects of Omega-3 Fatty Acid Supplementation on Diabetic Nephropathy Progression in Patients with Diabetes and Hypertriglyceridemia
por: Han, Eugene, et al.
Publicado: (2016)

Understanding hypertriglyceridemia in women: clinical impact and management with prescription omega-3-acid ethyl esters
por: Dayspring, Thomas D
Publicado: (2011)

The effect of bezafibrate and omega-3 fatty acids on lymphocyte cytokine release and systemic inflammation in patients with isolated hypertriglyceridemia
por: Krysiak, Robert, et al.
Publicado: (2011)

Omega-3 Fatty Acids for the Management of Osteoarthritis: A Narrative Review
por: Cordingley, Dean M., et al.
Publicado: (2022)

Current and Emerging Therapies for Atherosclerotic Cardiovascular Disease Risk Reduction in Hypertriglyceridemia
por: Mszar, Reed, et al.
Publicado: (2023)

Patient with Hypertriglyceridemia, Type 2 Diabetes, and Chronic Kidney Disease Treated with Atorvastatin and Omega-3 Fatty Acid Ethyl Esters
por: Athyros, Vasilios G, et al.
Publicado: (2012)

Cardiovascular, electrophysiologic, and hematologic effects of omega-3 fatty acids beyond reducing hypertriglyceridemia: as it pertains to the recently published REDUCE-IT trial
por: Sheikh, Omar, et al.
Publicado: (2019)

Efficacy and Safety of Omega-3 Fatty Acids in Patients Treated with Statins for Residual Hypertriglyceridemia: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial
por: Jun, Ji Eun, et al.
Publicado: (2020)

Omega 3 Fatty Acids vs Omega 6 Fatty Acids
por: Feliu, María, et al.
Publicado: (2022)

Cardioprotective Effects of Nutraceuticals: Focus on Omega-3 Polyunsaturated Fatty Acids
por: Sypniewska, Grazyna, et al.
Publicado: (2021)

A Head‐to‐Head Comparison of a Free Fatty Acid Formulation of Omega‐3 Pentaenoic Acids Versus Icosapent Ethyl in Adults With Hypertriglyceridemia: The ENHANCE‐IT Study
por: Maki, Kevin C., et al.
Publicado: (2022)

Egyptian practical guidance in hypertriglyceridemia management 2021
por: Taha, Hesham Salah El Din, et al.
Publicado: (2021)

ODP155 Successful Treatment of PEG-Asparaginase Related Hypertriglyceridemia with Omega-3 Acid Ethyl Esters
por: Radovanovic, Natasa, et al.
Publicado: (2022)

The effect of omega-3 fatty acids and its combination with statins on lipid profile in patients with hypertriglyceridemia: A systematic review and meta-analysis of randomized controlled trials
por: Yang, Yunjiao, et al.
Publicado: (2022)

Fellow's voice: Hypertriglyceridemia: Understanding the current guideline
por: Koneru, Sri Charitha
Publicado: (2022)

Impact of Dietary Fats on Cardiovascular Disease with a Specific Focus on Omega-3 Fatty Acids
por: Maggioni, Aldo Pietro, et al.
Publicado: (2022)

Efficacy and Safety of Prescription Omega-3 Fatty Acids Added to Stable Statin Therapy in Korean Patients with Type 2 Diabetes and Hypertriglyceridemia: a Randomized Controlled Trial
por: Son, Jang Won, et al.
Publicado: (2019)

Omega-3 fatty acid exposure with a low-fat diet in patients with past hypertriglyceridemia-induced acute pancreatitis; an exploratory, randomized, open-label crossover study
por: Dunbar, Richard L., et al.
Publicado: (2020)

Clinical Practice Guidelines Using GRADE and AGREE II for the Impact of Genetic Variants on Plasma Lipid/Lipoprotein/Apolipoprotein Responsiveness to Omega-3 Fatty Acids
por: Keathley, Justine, et al.
Publicado: (2022)

Omega-3 Fatty Acids and Insulin Resistance: Focus on the Regulation of Mitochondria and Endoplasmic Reticulum Stress
por: Lepretti, Marilena, et al.
Publicado: (2018)

Personalised medicine in child and Adolescent Psychiatry: Focus on omega-3 polyunsaturated fatty acids and ADHD
por: Pei-Chen Chang, Jane
Publicado: (2021)

Combined effect of obesity and uric acid on nonalcoholic fatty liver disease and hypertriglyceridemia
por: Zhang, Shujun, et al.
Publicado: (2017)

Effect of High-Dose Marine Omega-3 Fatty Acids on Atherosclerosis: A Systematic Review and Meta-Analysis of Randomized Clinical Trials
por: Sekikawa, Akira, et al.
Publicado: (2019)

Treatment of Chinese Patients with Hypertriglyceridemia with a Pharmaceutical-Grade Preparation of Highly Purified Omega-3 Polyunsaturated Fatty Acid Ethyl Esters: Main Results of a Randomized, Double-Blind, Controlled Trial
por: Qi, Litong, et al.
Publicado: (2021)

The Current Role of Omega-3 Fatty Acids in the Management of Atrial Fibrillation
por: Christou, Georgios A., et al.
Publicado: (2015)

Omega-9 fatty acids: potential roles in inflammation and cancer management
por: Farag, Mohamed A., et al.
Publicado: (2022)

Low-dose omega-3 fatty acids in margarines prove disappointing as secondary prevention
Publicado: (2010)

Effects of different doses of omega-3 polyunsaturated fatty acids on gut microbiota and immunity
por: Zhu, Xueliang, et al.
Publicado: (2021)

Omega-3 Fatty Acids in Early Prevention of Inflammatory Neurodegenerative Disease: A Focus on Alzheimer's Disease
por: Thomas, J., et al.
Publicado: (2015)

Cardiovascular Diseases and Marine Oils: A Focus on Omega-3 Polyunsaturated Fatty Acids and Polar Lipids
por: Caffrey, Cliodhna, et al.
Publicado: (2023)

Differential effects of high dose omega-3 fatty acids on metabolism and inflammation in patients with obesity: eicosapentaenoic and docosahexaenoic acid supplementation
por: Borja-Magno, Angélica, et al.
Publicado: (2023)

Erythrocyte Omega-3 Fatty Acid Content in Elite Athletes in Response to Omega-3 Supplementation: A Dose-Response Pilot Study
por: Drobnic, Franchek, et al.
Publicado: (2017)

Half Dose Once-Daily Pemafibrate Effectively Improved Hypertriglyceridemia in Real Practice
por: Iitake, Chie, et al.
Publicado: (2019)

Clinical and microbiological outcomes of subgingival instrumentation supplemented with high-dose omega-3 polyunsaturated fatty acids in periodontal treatment – a randomized clinical trial
por: Stańdo-Retecka, Mirella, et al.
Publicado: (2023)

Changes in plasma and erythrocyte omega-6 and omega-3 fatty acids in response to intravenous supply of omega-3 fatty acids in patients with hepatic colorectal metastases
por: Al-Taan, Omer, et al.
Publicado: (2013)

Omega-3 fatty acids for cardiovascular disease prevention: A practice tool for pharmacists
por: Barry, Arden R., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_n4hblp6ffg1vmrttluh99qcnet